Age-related changes in serum testosterone and sex hormone binding globulin in Australian men: Longitudinal analyses of two geographically separate regional cohorts

被引:104
作者
Liu, Peter Y.
Beilin, Jonathan
Meier, Christian
Nguyen, Tuan V.
Center, Jacqueline R.
Leedman, Peter J.
Seibel, Markus J.
Eisman, John A.
Handelsman, David J. [1 ]
机构
[1] Univ Sydney, Dept Androl, Concord Hosp, Sydney, NSW 2139, Australia
[2] Univ Sydney, ANZAC Res Inst, Sydney, NSW 2139, Australia
[3] Royal Perth Hosp, Dept Endocrinol & Diabet, Perth, WA 6847, Australia
[4] Univ Sydney, Bone Res Program, ANZAC Res Inst, Sydney, NSW 2006, Australia
[5] Univ Basel Hosp, Div Endocrinol Diabet Clin Nutr, CH-4031 Basel, Switzerland
[6] St Vincents Hosp, Garvan Inst Med Res, Sydney, NSW 2010, Australia
[7] Univ New S Wales, Sydney, NSW 2010, Australia
[8] Univ Western Australia, Sch Med & Pharmacol, Med Res Ctr, Lab Canc Med, Perth, WA 6000, Australia
[9] Western Australian Inst Med Res, Perth, WA 6000, Australia
基金
英国医学研究理事会;
关键词
D O I
10.1210/jc.2007-0862
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Cross-sectional studies from different populations show a variable decline in blood testosterone concentrations as men age. Few population representative cohorts have been followed up over time. Objective: The objective of the study was to quantify longitudinally the change in serum testosterone and SHBG concentrations with age in two well-defined, representative but geographically widely separated regional Australian cohorts. Subjects and Setting: The Busselton cohort comprises individuals aged 18-90 yr residing in Western Australia assessed prospectively since 1981. Sera were assayed from 910 men, from whom further samples were available 14 yr later in 480. The Dubbo cohort involves individuals aged 61-90 yr living in Eastern Australia. Baseline sera were collected from 610 men and additional sera on a second (n = 370) and third ( n = 200) occasion from 1989 to 2004. Men from both cohorts are community dwelling and of predominately European origin. Results: Longitudinal analyses show the following: 1) total testosterone declines comparably ( P > 0.9) by 1.3% ( Busselton) and 0.9% ( Dubbo) per annum with the same rates of decline when analyses were restricted to men older than 60 yr of age; 2) annual changes in SHBG were also very similar in age- restricted analyses (2.3% vs. 2.5%, P = 0.48); and 3) the annual increase in SHBG was steeper in middle-aged and older men ( P < 10(-3) vs. young men). These longitudinal changes were all up to 4-fold greater in magnitude, compared with cross-sectional analyses of baseline data. Conclusion: In two separate regional Australian populations, blood testosterone fell and SHBG increased comparably with age. Agerelated changes in blood testosterone and SHBG previously described in urban-dwelling men are the same in men who reside in smaller regional cities of another continent.
引用
收藏
页码:3599 / 3603
页数:5
相关论文
共 20 条
[1]  
BELANGER A, 1994, J CLIN ENDOCR METAB, V79, P1086
[2]  
BURKE V, 1998, BUSSELTON STUDY MAPP, V142
[3]   Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young men [J].
Diver, MJ ;
Imtiaz, KE ;
Ahmad, AM ;
Vora, JP ;
Fraser, WD .
CLINICAL ENDOCRINOLOGY, 2003, 58 (06) :710-717
[4]   Population variation in age-related decline in male salivary testosterone [J].
Ellison, PT ;
Bribiescas, RG ;
Bentley, GR ;
Campbell, BC ;
Lipson, SF ;
Panter-Brick, C ;
Hill, K .
HUMAN REPRODUCTION, 2002, 17 (12) :3251-3253
[5]  
Ferrini RL, 1998, AM J EPIDEMIOL, V147, P750
[6]  
Gapstur SM, 2002, CANCER EPIDEM BIOMAR, V11, P1041
[7]   AGE, DISEASE, AND CHANGING SEX-HORMONE LEVELS IN MIDDLE-AGED MEN - RESULTS OF THE MASSACHUSETTS MALE AGING STUDY [J].
GRAY, A ;
FELDMAN, HA ;
MCKINLAY, JB ;
LONGCOPE, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 73 (05) :1016-1025
[8]   Longitudinal effects of aging on serum total and free testosterone levels in healthy men [J].
Harman, SM ;
Metter, EJ ;
Tobin, JD ;
Pearson, J ;
Blackman, MR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (02) :724-731
[9]   The rationale, efficacy and safety of androgen therapy in older men: Future research and current practice recommendations [J].
Liu, PY ;
Swerdloff, RS ;
Veldhuis, JD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (10) :4789-4796
[10]   Androgens and cardiovascular disease [J].
Liu, PY ;
Death, AK ;
Handelsman, DJ .
ENDOCRINE REVIEWS, 2003, 24 (03) :313-340